Evidence map›Paper›PMID 38247218›Full record

ArticleJournal of microbiology and biotechnology2024

Ozonated Sunflower Oil (OSO) Alleviates Inflammatory Responses in Oxazolone-Induced Atopic Dermatitis (AD)-Like Mice and LPS-Treated RAW 264.7 Cells.

Su-Young Kim, Jung Ok Lee, Sue Lee, Jihye Heo, Kyung-Hyun Cho, Ashutosh Bahuguna, Kwang-Ho Yoo, Beom Joon Kim

Abstract read
In one paragraph

Article in Journal of microbiology and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Identification of Bioactive Medium Chain Fatty Acids (CAntioxidants (Basel, Switzerland) · 2026
    Article
  5. Topical ozone in atopic dermatitis: a viable treatment option?Archives of dermatological research · 2025
    Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Su-Young KimDepartment of Dermatology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea.
Jung Ok LeeDepartment of Dermatology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea.
Sue LeeDepartment of Dermatology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea.
Jihye HeoDepartment of Dermatology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea.
Kyung-Hyun ChoRaydel Research Institute, Medical Innovation Complex, Daegu 41061, Republic of Korea.
Ashutosh BahugunaRaydel Research Institute, Medical Innovation Complex, Daegu 41061, Republic of Korea.
Kwang-Ho YooDepartment of Dermatology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea.
Beom Joon KimDepartment of Dermatology, College of Medicine, Chung-Ang University, Seoul 06974, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ozone, a highly reactive oxidant molecule, is widely used as a complementary therapy for various skin diseases, including wound healing, pressure ulcers, diabetic foot, and infections. However, there is limited research on the effectiveness of ozone for atopic dermatitis (AD). Ozonated sunflower oil (OSO) is an active ingredient obtained from partially ozonated sunflower oil (SO). OSO markedly reduced the LPS-induced increase in IL-1β and nitric oxide (NO) levels in RAW 264.7 mouse macrophage cells. Oxazolone (OXZ) was applied to hairless mice to induce AD-like skin symptoms and immune response. OSO significantly alleviated the OXZ-induced increases in the number of infiltrating mast cells, epidermal thickness, AD symptoms, thymic stromal lymphopoietin (TSLP), and filaggrin, as well as the serum levels of NO, IgE, IL-1β, and TNF-α. Furthermore, OSO inhibited the IL-4/STAT3/MAPK pathway and the expression of NF-κB. Our results suggest that OSO treatment could relieve AD-mediated skin damage through its anti-inflammatory and antioxidant activities. Therefore, it can be used as a therapeutic agent against AD-related skin diseases.

Indexed as

CytokinesDermatitis, AtopicLipopolysaccharidesNitric OxideOxazoloneOzoneSunflower OilAnimalsAnti-Inflammatory AgentsDisease Models, AnimalFilaggrin ProteinsImmunoglobulin EInflammationInterleukin-1betaInterleukin-4MacrophagesAnti-Inflammatory AgentsCytokinesFilaggrin ProteinsImmunoglobulin EInterleukin-1betaInterleukin-4LipopolysaccharidesNF-kappa BNitric OxideOxazoloneOzoneSTAT3 Transcription FactorSunflower OilThymic Stromal LymphopoietinTumor Necrosis Factor-alphaAtopic dermatitis (AD)filaggrininflammationOzonated sunflower oil (OSO)RAW 264.7TSLP

Identifiers

PMID38247218
PMCPMC11091665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.